Advances in ophthalmological technologies are making way for more exact post-op outcomes. Newsom Eye’s T. Hunter Newsom, M.D., has been at the forefront of RxSight’s Light Adjustable Lens FDA trials, with 80% of trial patients seeing 20/20 or clearer results. Read the full article in OutPatient Surgery Magazine’s April issue.